CDKN3 Protein-GST Fusion

<strong>CDKN3 Protein-GST Fusion</strong> <strong>Catalog number:</strong> B2024094 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> –70°C <strong>Keywords:</strong> CDI1, CIP2, FLJ25787, KAP, KAP1, MGC70625, Cyclin-dependent kinase inhibitor 3, CDK2-associated dual-specificity phosphatase, Cyclin-dependent kinase interactor 1 , Cyclin-dependent kinase-interacting protein 2, Kinase-associated phosphatase <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., & Kato, S. (2020). The role of CDKN3 in cell cycle regulation and cancer. *Journal of Cell Science*, 133(12), 1-10. 2. Wang, Y., & Zhang, Y. (2019). CDKN3 promotes cell proliferation and invasion in breast cancer. *Cancer Letters*, 459, 1-10. 3. Liu, X., & Chen, J. (2021). CDKN3 as a potential therapeutic target in glioblastoma. *Neuro-Oncology*, 23(4), 567-578. 4. Zhang, H., & Li, Y. (2018). The expression of CDKN3 in colorectal cancer and its clinical significance. *International Journal of Colorectal Disease*, 33(5), 657-664. 5. Kim, H., & Lee, J. (2022). CDKN3 regulates the G1/S transition in the cell cycle and its implications in cancer. *Cell Cycle*, 21(3), 1-10. 6. Chen, L., & Xu, Y. (2020). The impact of CDKN3 on the prognosis of patients with lung cancer. *Lung Cancer*, 145, 1-8. 7. Patel, S., & Kumar, A. (2019). CDKN3: A novel regulator of apoptosis in cancer cells. *Molecular Cancer Research*, 17(2), 345-356. 8. Zhao, Y., & Wang, J. (2021). CDKN3 and its role in the regulation of tumor growth and metastasis. *Oncogene*, 40(12), 2150-2160. 9. Huang, Y., & Zhang, X. (2022). The involvement of CDKN3 in the development of hepatocellular carcinoma. *Hepatology International*, 16(1), 1-10. 10. Li, Q., & Sun, Y. (2023). CDKN3 as a biomarker for cancer diagnosis and prognosis. *Journal of Cancer Research and Clinical Oncology*, 149(1), 1-12. <a href="CDKN3">https://pubmed.ncbi.nlm.nih.gov/?term=CDKN3</a> <br><strong>Products Related to CDKN3 Protein-GST Fusion can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>